Global Wealth Management Investment Advisory’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-11,499
| Closed | -$1.37M | – | 149 |
|
|
2024
Q3 | $1.37M | Buy |
11,499
+441
| +4% | +$52.5K | 0.3% | 85 |
|
|
2024
Q2 | $1.58M | Buy |
11,058
+374
| +4% | +$53.4K | 0.37% | 73 |
|
|
2024
Q1 | $1.37M | Buy |
10,684
+10,268
| +2,468% | +$1.32M | 0.34% | 79 |
|
|
2023
Q4 | $43K | Buy |
416
+6
| +1% | +$621 | 0.01% | 201 |
|
|
2023
Q3 | $37.3K | Hold |
410
| – | – | 0.01% | 209 |
|
|
2023
Q2 | $33.2K | Buy |
+410
| New | +$33.2K | 0.01% | 217 |
|
|
2022
Q3 | – | Sell |
-410
| Closed | -$23K | – | 357 |
|
|
2022
Q2 | $23K | Hold |
410
| – | – | 0.01% | 230 |
|
|
2022
Q1 | $23K | Hold |
410
| – | – | 0.01% | 248 |
|
|
2021
Q4 | $23K | Hold |
410
| – | – | 0.01% | 246 |
|
|
2021
Q3 | $20K | Hold |
410
| – | – | 0.01% | 261 |
|
|
2021
Q2 | $17K | Hold |
410
| – | – | 0.01% | 258 |
|
|
2021
Q1 | $14K | Hold |
410
| – | – | 0.01% | 281 |
|
|
2020
Q4 | $14K | Hold |
410
| – | – | 0.01% | 255 |
|
|
2020
Q3 | $14K | Hold |
410
| – | – | 0.01% | 253 |
|
|
2020
Q2 | $13K | Hold |
410
| – | – | 0.01% | 322 |
|
|
2020
Q1 | $12K | Hold |
410
| – | – | 0.01% | 309 |
|
|
2019
Q4 | $12K | Hold |
410
| – | – | 0.01% | 333 |
|
|
2019
Q3 | $11K | Hold |
410
| – | – | 0.01% | 315 |
|
|
2019
Q2 | $10K | Hold |
410
| – | – | ﹤0.01% | 369 |
|
|
2019
Q1 | $11K | Sell |
410
-372
| -48% | -$9.98K | 0.01% | 369 |
|
|
2018
Q4 | $18K | Buy |
+782
| New | +$18K | 0.01% | 311 |
|